Advertisement
Advertisement

HBIO

HBIO logo

Harvard Bioscience Inc.

2.05
USD
-0.125
-5.76%
Dec 18, 15:39 UTC -5
Open

Harvard Bioscience Inc. Profile

About

HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.

Info & Links

CEO

James Green

Headquarters

84 OCTOBER HILL RD
HOLLISTON, MA 01746, UNITED STATES

Industry

Medical Specialties

Sector

Health Technology

Website

www.harvardbioscience.com

Auditor

GRANT THORNTON LLP

Share holders

90

Employees

416

Harvard Bioscience Inc. Statistics

Valuation Measures

Market Capitalization2

89.20M

Enterprise Value

122.49M

Enterprise Value/EBITDA(ttm)

79.90

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.96

Price to Book(mrq)

1.44

Price to Cash(ytd)

9.45

Profitability

Gross Margin(ttm)

58.40%

Operating Margin(ttm)

-3.26%

Profit Margin(ttm)

-15.03%

Return on Equity(ttm)

-4.64%

Return on Invested Capital(ttm)

-14.19%

Return on Assets(ttm)

-2.40%

Income Statement

Revenue(ttm)

97.73M

Revenue Per Share(ttm)

2.24

Gross Profit(ttm)

57.08M

EBITDA(ttm)3

1.53M

Net Income Available to Common(ttm)

-14.24M

Diluted EPS(ttm)

-0.33

Share Statistics

Beta (5Y Monthly)

1.27

52-Week Change

-55.05%

S&P 500 52-Week Change

25.41%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

43.62M

Dividend Yield

0.00%

Float4

39.69M

% Held by Insiders

9.00%

% Held by Institutions

80.87%

Balance Sheet

Total Cash(mrq)

4.57M

Total Cash Per Share(mrq)

0.10

Total Debt(mrq)

37.86M

Total Debt/Equity(mrq)

57.96%

Current Ratio(mrq)

2.06%

Quick Ratio(mrq)

0.91%

Book Value Per Share(mrq)

1.50

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.01

Free Cash Flow(ytd)

-2.63M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement